« Back
Home /
Fasiglifam

Fasiglifam

Manufacturer	MedChem Express
Category	Metabolism Diabetes Glucose Homeostasis Cholesterol & Lipid Metabolism Regulation of Appetite Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	200 mg
Item no.	HY-10480-200mg
Targets	GPR40
CASRN	1000413-72-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Fasiglifam (TAK-875) is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 72 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	524.63
Clinical_Information	Phase 3
Manufacturers Research_Area	Metabolic Disease
Solubility	DMSO : ≥ 128 mg/mL
Manufacturers Target	Free Fatty Acid Receptor
Pathway	GPCR/G Protein
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-10480-200mg-safety-datasheet.pdf